PM1032

· Biotheus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PM1032, covering 2023-05-06 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]